0.2 DAN 5612
Pill imprint 0.2 DAN 5612 has been identified as Clonidine hydrochloride 0.2 mg.
Clonidine is used in the treatment of pain; adhd; high blood pressure; opiate withdrawal; smoking cessation (and more), and belongs to the drug class antiadrenergic agents, centrally acting. Risk cannot be ruled out during pregnancy.
Clonidine 0.2 mg is not subject to the Controlled Substances Act.
See also related documents.
Clonidine hydrochloride Images
- Imprint:
-
0.2
DAN 5612 - Strength:
- 0.2 mg
- Color:
- Yellow
- Shape:
- Five-sided
- Availability:
- Prescription only
- Drug Class:
- Antiadrenergic agents, centrally acting
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals
Advertisement
More Clonidine Hydrochloride resources
- Clonidine
- Clonidine (Wolters Kluwer)
- Clonidine Extended-Release Tablets (Wolters Kluwer)
- Clonidine Patches (Wolters Kluwer)
- Clonidine Tablets (Wolters Kluwer)
- clonidine (Cerner Multum)
- clonidine transdermal (Cerner Multum)
- clonidine Epidural (Micromedex) - Includes Dosage Information
- clonidine Oral, Transdermal (Micromedex) - Includes Dosage Information
- clonidine Transdermal (Micromedex) - Includes Dosage Information
- Clonidine (AHFS DI)
- Clonidine Injection (FDA)
- Clonidine Patch (FDA)
- Clonidine Tablets (FDA)
- Clonidine Hydrochloride (Wolters Kluwer)
Clonidine Hydrochloride is associated with the treatment of:
- ADHD
- Alcohol Withdrawal
- Anxiety
- Atrial Fibrillation
- Benzodiazepine Withdrawal
- Bipolar Disorder
- High Blood Pressure
- Hyperhidrosis
- Hypertensive Emergency
- Insomnia, Stimulant-Associated
- Migraine Prevention
- Opiate Withdrawal
- Pain
- Perimenopausal Symptoms
- Persisting Pain, Shingles
- Pheochromocytoma Diagnosis
- Postanesthetic Shivering
- Restless Legs Syndrome
- Smoking Cessation
- Tardive Dyskinesia
- Tourette's Syndrome
- Ulcerative Colitis
Search Again
